FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer

NCT01503372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Pazopanib
DRUG: 5-FU, Oxaliplatin, Leukovorin (FLO)

Sponsor

Charite University, Berlin, Germany